Standard

In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms. / Smelov, V.; Perekalina, T.; Gorelov, A.; Smelova, N.; Artemenko, N.; Norman, L.

в: European Urology, Том 46, № 5, 01.11.2004, стр. 647-650.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Smelov, V, Perekalina, T, Gorelov, A, Smelova, N, Artemenko, N & Norman, L 2004, 'In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms', European Urology, Том. 46, № 5, стр. 647-650. https://doi.org/10.1016/j.eururo.2004.06.020

APA

Smelov, V., Perekalina, T., Gorelov, A., Smelova, N., Artemenko, N., & Norman, L. (2004). In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms. European Urology, 46(5), 647-650. https://doi.org/10.1016/j.eururo.2004.06.020

Vancouver

Smelov V, Perekalina T, Gorelov A, Smelova N, Artemenko N, Norman L. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms. European Urology. 2004 Нояб. 1;46(5):647-650. https://doi.org/10.1016/j.eururo.2004.06.020

Author

Smelov, V. ; Perekalina, T. ; Gorelov, A. ; Smelova, N. ; Artemenko, N. ; Norman, L. / In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms. в: European Urology. 2004 ; Том 46, № 5. стр. 647-650.

BibTeX

@article{5d8b00b6014448dcb7b2654131d20f39,
title = "In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms",
abstract = "Little is known about chlamydia survival in the presence of fluoroquinolones in patients with chronic prostatitis syndrome (CPS). In vitro activities of four fluoroquinolones, azithromycin and doxycycline against C. trachomatis in patients with CPS being not treated with antibiotics earlier were investigated and compared. Chlamydia survival in 304 patients with CPS being not treated with antibiotics earlier was analysed and compared. Infection by C. trachomatis was determined in the urethra and expressed prostatic secretion by cell culture test. Azithromycin and ofloxacin were found to be the most active antichlamydial agent with ciprofloxacin and doxycycline being least active. Ofloxacin can be recommended as the primary drug in the treatment of chlamydia-infected patients with CPS. The decision on the prescription of other fluoroquinolones should be made individually. The investigation of chlamydia survival in the presence of antibiotics in patients with CPS and C. trachomatis prior to treatment is recommended.",
keywords = "Antibacterial treatment, Chlamydia trachomatis, Chronic prostatitis, Fluoroquinolones",
author = "V. Smelov and T. Perekalina and A. Gorelov and N. Smelova and N. Artemenko and L. Norman",
year = "2004",
month = nov,
day = "1",
doi = "10.1016/j.eururo.2004.06.020",
language = "English",
volume = "46",
pages = "647--650",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms

AU - Smelov, V.

AU - Perekalina, T.

AU - Gorelov, A.

AU - Smelova, N.

AU - Artemenko, N.

AU - Norman, L.

PY - 2004/11/1

Y1 - 2004/11/1

N2 - Little is known about chlamydia survival in the presence of fluoroquinolones in patients with chronic prostatitis syndrome (CPS). In vitro activities of four fluoroquinolones, azithromycin and doxycycline against C. trachomatis in patients with CPS being not treated with antibiotics earlier were investigated and compared. Chlamydia survival in 304 patients with CPS being not treated with antibiotics earlier was analysed and compared. Infection by C. trachomatis was determined in the urethra and expressed prostatic secretion by cell culture test. Azithromycin and ofloxacin were found to be the most active antichlamydial agent with ciprofloxacin and doxycycline being least active. Ofloxacin can be recommended as the primary drug in the treatment of chlamydia-infected patients with CPS. The decision on the prescription of other fluoroquinolones should be made individually. The investigation of chlamydia survival in the presence of antibiotics in patients with CPS and C. trachomatis prior to treatment is recommended.

AB - Little is known about chlamydia survival in the presence of fluoroquinolones in patients with chronic prostatitis syndrome (CPS). In vitro activities of four fluoroquinolones, azithromycin and doxycycline against C. trachomatis in patients with CPS being not treated with antibiotics earlier were investigated and compared. Chlamydia survival in 304 patients with CPS being not treated with antibiotics earlier was analysed and compared. Infection by C. trachomatis was determined in the urethra and expressed prostatic secretion by cell culture test. Azithromycin and ofloxacin were found to be the most active antichlamydial agent with ciprofloxacin and doxycycline being least active. Ofloxacin can be recommended as the primary drug in the treatment of chlamydia-infected patients with CPS. The decision on the prescription of other fluoroquinolones should be made individually. The investigation of chlamydia survival in the presence of antibiotics in patients with CPS and C. trachomatis prior to treatment is recommended.

KW - Antibacterial treatment

KW - Chlamydia trachomatis

KW - Chronic prostatitis

KW - Fluoroquinolones

UR - http://www.scopus.com/inward/record.url?scp=5144234874&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2004.06.020

DO - 10.1016/j.eururo.2004.06.020

M3 - Article

C2 - 15474277

AN - SCOPUS:5144234874

VL - 46

SP - 647

EP - 650

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 5

ER -

ID: 39795590